Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.

Viscidi RP, Hill PM, Li SJ, Cerny EH, Vlahov D, Farzadegan H, Halsey N, Kelen GD, Quinn TC.

J Acquir Immune Defic Syndr. 1991;4(12):1190-8.

PMID:
1941526
2.

Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.

Blomberg J, Robert-Guroff M, Blattner WA, Pipkorn R.

J Acquir Immune Defic Syndr. 1992;5(3):294-302.

PMID:
1371319
3.

Lack of specificity of HTLV antibody enzyme immunoassays.

Jang D, Mahony JB, Sellors JW, Galli R, Gregory B, Chernesky MA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 15;9(5):523-4. No abstract available.

PMID:
7627628
4.

Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.

Lal RB, Rudolph DL, Lairmore MD, Khabbaz RF, Garfield M, Coligan JE, Folks TM.

J Infect Dis. 1991 Jan;163(1):41-6.

PMID:
1984475
5.

Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.

Hernández Marin M, Castellanos Pentón P, Márquez Bocalandro Y, Pozo Peña L, Díaz Navarro J, González López LJ.

Biochem Biophys Res Commun. 2001 Nov 23;289(1):7-12.

PMID:
11708768
6.

Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.

Tosswill JH, McAlpine L, Mortimer PP.

J Med Virol. 1993 May;40(1):83-5.

PMID:
8099946
9.

Detection of human T-lymphotropic virus type-I/II env antibodies by immunoassays using recombinant fusion proteins.

Rudolph DL, Khabbaz RF, Folks TM, Lal RB.

Diagn Microbiol Infect Dis. 1993 Jul;17(1):35-9.

PMID:
8102953
10.

Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.

Lal RB, Rudolph DL, Kaplan JE, Hjelle B, Levine PH, Coligan JE, Viscidi RP.

Virology. 1992 Jan;186(1):274-9.

PMID:
1727602
11.

Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.

Hernández Marin M, Castellanos Pentón P, Márquez Bocalandro Y, Pozo Peña L, Díaz Navarro J, González López LJ.

Biochem Biophys Res Commun. 2001 Nov 23;289(1):1-6.

PMID:
11708767
12.

Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens.

Washitani Y, Kuroda N, Shiraki H, Nishimura Y, Yamaguchi K, Takatsuki K, Fernando LP, Fang CT, Kiyokawa H, Maeda Y.

Int J Cancer. 1991 Sep 9;49(2):173-7.

PMID:
1879964
13.

Prototypical HTLV-I/II infection is rare in LGL leukemia.

Loughran TP Jr, Sherman MP, Ruscetti FW, Frey S, Coyle T, Montagna RA, Jones B, Starkebaum G, Poiesz BJ.

Leuk Res. 1994 Jun;18(6):423-9.

PMID:
8207960
15.

Sera of patients with rheumatoid arthritis contain antibodies to recombinant human T-lymphotrophic virus type I/II envelope glycoprotein p21.

Starkebaum G, Shasteen NM, Fleming-Jones RM, Loughran TP Jr, Mannik M.

Clin Immunol Immunopathol. 1996 May;79(2):182-8.

PMID:
8620624
16.

Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.

Roberts BD, Foung SK, Lipka JJ, Kaplan JE, Hadlock KG, Reyes GR, Chan L, Heneine W, Khabbaz RF.

J Clin Microbiol. 1993 Feb;31(2):260-4.

17.

Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype.

Morimoto HK, Morimoto AA, Reiche EM, Ueda LT, Matsuo T, Reiche FV, Caterino-de-Araujo A.

Rev Inst Med Trop Sao Paulo. 2007 Jul-Aug;49(4):225-30.

20.

Serologic differentiation of human T lymphotropic virus type I from type II infection by synthetic peptide immunoassays.

Roberts CR, Mitra R, Hyams K, Brodine SK, Lal RB.

J Med Virol. 1992 Apr;36(4):298-302.

PMID:
1578221

Supplemental Content

Support Center